Articles liés à JOURNAVX FOR PAIN RELIEF: Non-Opioid Solution for Safer...

JOURNAVX FOR PAIN RELIEF: Non-Opioid Solution for Safer and More Effective Pain Management - Couverture souple

M . Hoffmann, Dr Felix

 
9798311815680: JOURNAVX FOR PAIN RELIEF: Non-Opioid Solution for Safer and More Effective Pain Management
Couverture souple
ISBN 13 : 9798311815680
Editeur : Independently published, 2025

Synopsis

Discover a groundbreaking approach to pain management with "JOURNAVX for Pain Relief: Non-Opioid Solution for Safer and More Effective Pain Management." This comprehensive guide introduces you to JOURNAVX (suzetrigine), the first FDA-approved non-opioid analgesic in over two decades, designed to treat moderate to severe acute pain in adults.
Unlike traditional opioids that act on the brain and carry risks of addiction, JOURNAVX targets sodium channels in the peripheral nervous system, effectively blocking pain signals before they reach the brain. This novel mechanism offers potent pain relief without the associated risks of dependency.
In this book, you'll explore the science behind JOURNAVX, its development journey, and its clinical applications. Gain insights into how this medication is transforming pain management practices and providing a safer alternative for patients and healthcare providers.
Empower yourself with knowledge about this innovative pain relief option and understand how JOURNAVX is paving the way for a new era in pain management

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
Independently published
Date d'édition
2025
Langue
anglais
ISBN 13 
9798311815680
Reliure
Broché
Nombre de pages
89
Coordonnées du fabricant
Manufactured by Amazon on behalf of the author
https://www.amazon.fr/hz/contact-us

c/o Amazon Media EU S.à.r.l., 38 Avenue John F. Kennedy
Luxembourg
L-1855
Luxembourg